The regulatory network of Mfsd2a in cerebral ischemia: a novel time-targeted intervention framework.

Cerebral ischemia‒reperfusion injury disrupts blood-brain barrier (BBB) integrity, a process strongly linked to the downregulation of the lipid transporter Mfsd2a. Prior research has focused on the consequences of Mfsd2a loss; however, a systematic synthesis of its upstream regulatory network is lacking. Here, we propose an integrated "Layered and Phased" (L&P) regulatory model as a new conceptual framework in which acute/hyperacute suppression is driven by rapid stress‑responsive transcription factors and microRNAs, while sustained silencing in the subacute/repair phase (days to weeks) may be consolidated by durable epigenetic reprogramming and potentially modulated by dynamic ceRNA networks. We categorized the evidence supporting each mechanism as strong (directly validated in cerebral ischemia models), preliminary (correlative or extrapolated), or predicted/hypothesized (bioinformatics-based). Based on this model, we propose phase‑specific therapeutic strategies, discuss major translational challenges, and outline how this framework can guide biomarker discovery and patient stratification. This L&P framework presents testable hypotheses regarding phase-dependent regulating switches. We outlined the key experiments required to validate the model and discussed their potential to guide biomarker discovery and time-targeted intervention.